Grantham, Mayo, Van Otterloo & Co (GMO)’s Fabrinet FN Stock Holding History
Bought
Maintained
Sold
Other funds holding FN
WA
Grantham, Mayo, Van Otterloo & Co (GMO)'s FN Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Fabrinet (FN) in Q1 2026, closing a stake of 40,240 shares — an estimated $18.3M sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in FN in Q1 2016 and held it in 16 quarters. The position peaked at $35.8M in Q3 2025. 668 funds tracked by Wall St. Rank hold FN as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Fabrinet position as of Q1 2026 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 40,240 Fabrinet shares in Q1 2026, an estimated $18.3M.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Fabrinet in Q1 2016 and held it in 16 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Fabrinet position peaked at $35.8M in Q3 2025.
- 668 funds tracked by Wall St. Rank held Fabrinet as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.